Gender | eGFR (mL/min/1.73 m2) (CKD-EPI) | Urine ACR (mg/mmol) | LVMI (g/m2.7) | IVS (mm) | LPW (mm) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | After ERT | Baseline | After ERT | Baseline | After ERT | Baseline | After ERT | Baseline | After ERT | ||
Male | Mean | 87.63 | 90.96 | 8.0 | 1.5 | 68.9 | 63.3 | 15.0 | 13.5 | 11.8 | 10.7 |
SD | 21.2 | 23.1 | 25.3 | 2.6 | 25.2 | 24.3 | 4.7 | 3.7 | 5.1 | 2.3 | |
N | 20 | 19 | 16 | 17 | 17 | ||||||
p Value* | NS | NS | NS | NS | NS | ||||||
Female | Mean | 88.0 | 88.5 | 45.5 | 17.6 | 67.3 | 56.5 | 13.7 | 11.8 | 11.1 | 10.0 |
SD | 23.6 | 26.5 | 105.0 | 37.7 | 29.6 | 28.3 | 4.6 | 4.6 | 3.0 | 2.5 | |
N | 16 | 17 | 15 | 16 | 16 | ||||||
p Value* | NS | NS | 0.005 | 0.038 | 0.039 |
*Significance at p<0.05.
ACR, albumin-to-creatine ratio; CKD-EPI, chronic kidney disease epidemiology; eGFR, estimated glomerular filtration rate; IVS, intraventricular septum; LPW, left posterior wall; LVMI, left-ventricular mass index; NS, not significant.